Table 3.
Baseline recipient, donor and transplant characteristics in pre- and post-Safety Net KAL transplants.
| KAL - Pre-Safety Net | KAL - Safety Net | P-value | |
|---|---|---|---|
| Number | 80 | 132 | |
| Recipient characteristics | |||
| Age | 59 (52–63) | 58 (51–65) | 0.59 |
| Female Sex | 28 (35.0%) | 42 (31.8%) | 0.26 |
| Race | 0.16 | ||
| White | 64 (80.0%) | 88 (66.7%) | |
| Black | 6 (7.5%) | 11 (8.3%) | |
| Asian | 2 (2.5%) | 3 (2.3%) | |
| Other | 8 (10.0%) | 30 (22.7%) | |
| BMI | 27.1 (23.5–30.7) | 26.7 (23.1–31.0) | 0.02 |
| cPRA | 0 (0–50) | 0 (0–31) | 0.77 |
| Days on waitlist | 470 (105–932) | 57 (19–149) | 0.01 |
| Days between liver and kidney transplant | 737 (349–1225) | 446 (332–619) | <0.01 |
| Hemodialysis | 72 (90.0%) | 86 (65.1%) | <0.01 |
| Previous kidney transplant | 2 (2.5%) | 3 (2.3%) | 0.14 |
| Etiology of renal failure | <0.01 | ||
| ATN/HRS | 37 (46.2%) | 36 (27.3%) | |
| Diabetes mellitus | 23 (28.8%) | 69 (52.3%) | |
| Hypertension | 8 (10.0%) | 22 (16.7%) | |
| Other | 12 (15.0%) | 5 (3.7%) | |
| Donor characteristics | |||
| Age | 37 (24–47) | 41 (34–48) | 0.14 |
| Female Sex | 29 (36.3%) | 63 (47.7%) | 0.56 |
| BMI | 27.5 (23.3–30.6) | 27.5 (23.5–32.2) | 0.74 |
| Diabetes mellitus | 7 (8.8%) | 6 (4.6%) | 0.52 |
| Hypertension | 21 (26.2%) | 27 (20.4%) | 0.72 |
| Creatinine (mg/dl) | 0.90 (0.70–1.35) | 1.07 (0.80–1.41) | 0.05 |
| Bloodstream infection | 2 (2.5%) | 15 (11.4%) | 0.21 |
| KDPI (%) | 41 (22–63) | 44 (32–58) | 0.21 |
| Cause of death - CVA | 21 (26.3%) | 36 (27.3%) | 0.74 |
| Transplant details | |||
| Cold ischemia time (hours) | 17.2 (10.4–21.5) | 11.6 (8.2–15.8) | <0.01 |
Values are listed as median +/− interquartile range unless otherwise stated.
BMI, body mass index; cPRA, calculated panel reactive antibodies; ATN, acute tubular necrosis; HRS, hepatorenal syndrome; CVA, cerebrovascular accident; KDPI, Kidney Donor Profile Index.